ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.1
  1. ホーム
  2. /化合物

Pseudoephedrine Hydrochloride

HCID 9581
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
345-78-8
標準SMILES
CN[C@@H](C)[C@@H](O)c1ccccc1.Cl
InChIKey
BALXUFOVQVENIU-KXNXZCPBSA-N
分子式
C10H16ClNO
平均分子量
201.69 g/mol
単同位体質量
201.0920418

概要

Pseudoephedrine Hydrochloride is the hydrochloride salt form of pseudoephedrine, a phenethylamine and an diastereomer of ephedrine with sympathomimetic property. Pseudoephedrine hydrochloride displaces norepinephrine from storage vesicles in presynaptic neurones, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors. It also has weak direct agonist activity at alpha- and beta- adrenergic receptors. Receptor stimulation results in vasoconstriction and decreases nasal and sinus congestion.

名称と識別子

優先名称
Pseudoephedrine Hydrochloride
IUPAC
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride

名称と別名

PSEUDOEPHEDRINE HYDROCHLORIDEPseudoephedrine HclRhinalairOtrinolNovafed345-78-8d-Pseudoephedrine hydrochlorideSudafed 12 HourGalsudSudafed PlusSudafed 24 HourEfidac 24
名称をさらに表示
L(+)-Pseudoephedrine hydrochloride6V9V2RYJ8NNSC-33634Topcare 12 hour decongestantNSC-106567GALPSEUDD-(alpha-(1-Methylamino)ethyl)benzyl alcohol hydrochlorideDTXSID10889343

データベース識別子

CAS
345-78-8
PubChem CID
9581
DTXSID
DTXSID10889343
ChEMBL
CHEMBL1200724
UNII
6V9V2RYJ8N
EC Number
206-462-1

物性

構造計算による物性

極性表面積
32.3 Ų
水素結合供与体数
3
水素結合受容体数
2
回転可能結合数
3
重原子数
13
形式電荷
0
複雑度
121

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section132.1 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 261 reports by companies from 24 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

REACH registered substance: Pseudoephedrine hydrochloride (EC: 206-462-1)

Pseudoephedrine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Benzenemethanol, .alpha.-[1-(methylamino)ethyl]-,hydrochloride, [S-(R*,R*)]-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Exposure RoutesPseudoephedrine is readily and almost completely absorbed from the GI tract and there is no evidence of first-pass metabolism.
Toxicity Summary · 1 件

Pseudoephedrine acts directly on both alpha- and, to a lesser degree, beta-adrenergic receptors. Through direct action on alpha-adrenergic receptors in the mucosa of the respiratory tract, pseudoephedrine produces vasoconstriction. Pseudoephedrine relaxes bronchial smooth muscle by stimulating beta2-adrenergic receptors. Like ephedrine, pseudoephedrine releasing norepinephrine from its storage sites, an indirect effect. This is its main and direct mechanism of action. The displaced noradrenaline is released into the neuronal synapse where it is free to activate the postsynaptic adrenergic receptors.

化学と産業

薬理情報

Metabolism/MetabolitesHepatic. Half Life: 9-16 hours
FDA Pharmacological Classification · 4 件

PSEUDOEPHEDRINE HCL

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

PSEUDOEPHEDRINE HYDROCHLORIDE

alpha-Adrenergic Agonist [EPC]; Adrenergic alpha-Agonists [MoA]

MeSH Pharmacological Classification · 5 件

Agents, usually topical, that relieve itching (pruritus).

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

用途と製造

Uses · 1 件

For the treatment of nasal congestion, sinus congestion, Eustachian tube congestion, and vasomotor rhinitis, and as an adjunct to other agents in the optimum treatment of allergic rhinitis, croup, sinusitis, otitis media, and tracheobronchitis. Also used as first-line therapy of priapism.

関連反応

8 件
反応記録を作成
HRID 219487 の反応式
HRID 219487反応物としてuspto-grants-2012_06
HRID 333515 の反応式
HRID 333515反応物としてuspto-grants-2014_11
HRID 403100 の反応式
HRID 403100反応物としてuspto-grants-2014_06
HRID 1496673 の反応式
HRID 1496673反応物としてuspto-grants-2015_12
HRID 1629646 の反応式
HRID 1629646反応物としてuspto-grants-2014_07
HRID 1732428 の反応式
HRID 1732428生成物としてuspto-grants-1980_12
HRID 1907052 の反応式
HRID 1907052反応物としてuspto-grants-2013_12
HRID 2195563 の反応式
HRID 2195563反応物としてuspto-grants-2012_12

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Signs and Symptoms · 1 件

Common adverse reactions include nervousness, restlessness, and insomnia. Rare adverse reactions include difficult/painful urination, dizziness/lightheadedness, heart palpitations, headache, increased sweating, nausea/vomiting, trembling, troubled breathing, unusual paleness, and weakness.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Pseudoephedrine hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

General Manufacturing InformationBenzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, hydrochloride (1:1), (.alpha.S)-: ACTIVE